摘要 |
<p>The present inventors used the previously developed H77/JFH 1T27OOC,A4O8OT (la/2a), J4/JFH 1T2996C,A4827T,?HVRI (lb/2a), J6/JFH 1?HVRI (2a/2a), J8/JFH 1?HVRI (2b/2a), S52/JFH lT27i8G,t7i6oc (3a/2a), SA13/JFH 1C34O5G,A3696G (5a/2a) and HK6a/JFH lT1389c,A1590G (6a/2a) constructs for the deletion of Hypervariable Region 1 (HVRl) to construct viable, JFH l (genotype 2a) based, genomes. The present inventors serially passaged the viruses in cell culture obtaining relatively high HCV RNA titers and infectivity titers. Sequence analysis of the viruses identified mutations adapting H77/JFH 1T27OOC,A4O8OT,?HVR1 (la/2a), J8/JFH 1?HVR1 (2b/2a), S52/JFH 1T2718G,T716OC,?HVR1 (3a/2a) and J4/JFH 1T2996C,A4827T,?HVR1 (lb/2a) to the HVRl deletion.</p> |
申请人 |
HVIDOVRE HOSPITAL;KOEBENHAVNS UNIVERSITET;PRENTOE, JANNICK;GOTTWEIN, JUDITH MARGARETE;SCHEEL, TROELS KASPER HOEYER;JENSEN, TANJA BERTELSEN;BUKH, JENS |
发明人 |
PRENTOE, JANNICK;GOTTWEIN, JUDITH MARGARETE;SCHEEL, TROELS KASPER HOEYER;JENSEN, TANJA BERTELSEN;BUKH, JENS |